End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,960 CZK | +0.67% | +0.40% | -4.23% |
Mar. 26 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Philip Morris CR a.s.(SEP:TABAK) dropped from FTSE All-World Index | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company returns high margins, thereby supporting business profitability.
- This company will be of major interest to investors in search of a high dividend stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.23% | 1.8B | - | ||
+5.21% | 68.12B | B- | ||
+7.45% | 21.02B | A- | ||
+33.54% | 6.81B | B- | ||
+84.68% | 2.43B | - | C+ | |
-2.75% | 1.73B | - | D+ | |
-28.76% | 1.18B | - | B+ | |
-.--% | 653M | - | - | |
+24.66% | 578M | C+ | ||
-20.16% | 429M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TABAK Stock
- Ratings Philip Morris CR